炎症性肠病患者-话题@MedSci

#炎症性肠病患者#

199篇内容 | 3814人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2214210, encodeId=6d832214210af, content=Ready for editorial assignment 这个状态1w了，真难顶<a href='/topic/show?id=508e6e03203' target=_blank style='color:#2F92EE;'>#炎症性肠病患者#</a>, objectTitle=SCI REP-UK, objectType=tool_impact_factor, longId=12086, objectId=017012086, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/images/journal/cover/2021/nzd_202109271316349490.jpg, objectUrl=/sci/submit.do?id=017012086, replyNumber=3, likeNumber=55, createdTime=2024-07-10, rootId=0, userName=ms3000000691298775, userId=9d4c8320348, projectId=1, avatar=null, status=1, hasArticle=1, attachment=null, ipAttribution=江西省, moduleDTOList=[ModuleDTO(moduleId=017012086, moduleTitle=SCI REP-UK, moduleType=tool_impact_factor, hrefUrl=https://www.medsci.cn/sci/submit.do?id=017012086)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1600154, encodeId=ebf6160015443, content=<a href='/topic/show?id=508e6e03203' target=_blank style='color:#2F92EE;'>#炎症性肠病患者#</a>, objectTitle=UEG: 炎症性肠病患者患尖锐湿疣的风险明显增加, objectType=article, longId=739234, objectId=2364e39234d8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2364e39234d8, replyNumber=0, likeNumber=95, createdTime=2022-09-15, rootId=0, userName=huangshifeng, userId=a9fa18776644, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2364e39234d8, moduleTitle=UEG: 炎症性肠病患者患尖锐湿疣的风险明显增加, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2364e39234d8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1600153, encodeId=38ec1600153f3, content=<a href='/topic/show?id=508e6e03203' target=_blank style='color:#2F92EE;'>#炎症性肠病患者#</a>, objectTitle=JGH：硫唑嘌呤治疗不会导致炎症性肠病患者淋巴瘤和非黑色素瘤皮肤癌的风险增加, objectType=article, longId=735611, objectId=29e0e3561170, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=29e0e3561170, replyNumber=0, likeNumber=89, createdTime=2022-08-12, rootId=0, userName=huangshifeng, userId=a9fa18776644, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=29e0e3561170, moduleTitle=JGH：硫唑嘌呤治疗不会导致炎症性肠病患者淋巴瘤和非黑色素瘤皮肤癌的风险增加, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=29e0e3561170)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1600152, encodeId=513d1600152b0, content=<a href='/topic/show?id=508e6e03203' target=_blank style='color:#2F92EE;'>#炎症性肠病患者#</a>, objectTitle=AP&T: 炎症性肠病患者患痴呆风险明显增加, objectType=article, longId=735602, objectId=2e17e35602c5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2e17e35602c5, replyNumber=0, likeNumber=83, createdTime=2022-08-12, rootId=0, userName=huangshifeng, userId=a9fa18776644, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2e17e35602c5, moduleTitle=AP&T: 炎症性肠病患者患痴呆风险明显增加, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2e17e35602c5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1600151, encodeId=342d160015179, content=<a href='/topic/show?id=508e6e03203' target=_blank style='color:#2F92EE;'>#炎症性肠病患者#</a>, objectTitle=IBD: 炎症性肠病患者接受抗TNF治疗前后严重感染的风险变化, objectType=article, longId=731932, objectId=044de31932fc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=044de31932fc, replyNumber=0, likeNumber=133, createdTime=2022-07-11, rootId=0, userName=huangshifeng, userId=a9fa18776644, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=044de31932fc, moduleTitle=IBD: 炎症性肠病患者接受抗TNF治疗前后严重感染的风险变化, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=044de31932fc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1600150, encodeId=214516001502e, content=<a href='/topic/show?id=508e6e03203' target=_blank style='color:#2F92EE;'>#炎症性肠病患者#</a>, objectTitle=Clin Trans Gastroenterology: 载脂蛋白C3在炎症性肠病患者中明显下调可能影响心血管疾病, objectType=article, longId=731175, objectId=5bd2e3117531, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5bd2e3117531, replyNumber=0, likeNumber=64, createdTime=2022-07-05, rootId=0, userName=huangshifeng, userId=a9fa18776644, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5bd2e3117531, moduleTitle=Clin Trans Gastroenterology: 载脂蛋白C3在炎症性肠病患者中明显下调可能影响心血管疾病, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5bd2e3117531)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1600149, encodeId=38ab16001491e, content=<a href='/topic/show?id=508e6e03203' target=_blank style='color:#2F92EE;'>#炎症性肠病患者#</a>, objectTitle=Gastroenterology：接受腹部手术的炎症性肠病患者术前肿瘤坏死因子抑制剂的治疗的安全性分析, objectType=article, longId=730498, objectId=0be2e30498a9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0be2e30498a9, replyNumber=0, likeNumber=69, createdTime=2022-06-27, rootId=0, userName=huangshifeng, userId=a9fa18776644, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0be2e30498a9, moduleTitle=Gastroenterology：接受腹部手术的炎症性肠病患者术前肿瘤坏死因子抑制剂的治疗的安全性分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0be2e30498a9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1600148, encodeId=341816001484a, content=<a href='/topic/show?id=508e6e03203' target=_blank style='color:#2F92EE;'>#炎症性肠病患者#</a>, objectTitle=AJG: 英夫利昔单抗与炎症性肠病患者的一般长期体重增加无关, objectType=article, longId=730071, objectId=cc30e3007151, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cc30e3007151, replyNumber=0, likeNumber=108, createdTime=2022-06-22, rootId=0, userName=huangshifeng, userId=a9fa18776644, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cc30e3007151, moduleTitle=AJG: 英夫利昔单抗与炎症性肠病患者的一般长期体重增加无关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cc30e3007151)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1600147, encodeId=161c160014e74, content=<a href='/topic/show?id=508e6e03203' target=_blank style='color:#2F92EE;'>#炎症性肠病患者#</a>, objectTitle=JGH：乌司奴单抗(Ustekinumab)不会增加既往患有恶性肿瘤的炎症性肠病患者新发或复发癌症的风险, objectType=article, longId=729950, objectId=a49de299506f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a49de299506f, replyNumber=0, likeNumber=95, createdTime=2022-06-21, rootId=0, userName=huangshifeng, userId=a9fa18776644, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a49de299506f, moduleTitle=JGH：乌司奴单抗(Ustekinumab)不会增加既往患有恶性肿瘤的炎症性肠病患者新发或复发癌症的风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a49de299506f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1600145, encodeId=3c0f16001455d, content=<a href='/topic/show?id=508e6e03203' target=_blank style='color:#2F92EE;'>#炎症性肠病患者#</a>, objectTitle=IBD: 炎症性肠病患者的结直肠狭窄不能独立预测结直肠肿瘤, objectType=article, longId=729176, objectId=ebb3e291762a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ebb3e291762a, replyNumber=0, likeNumber=133, createdTime=2022-06-13, rootId=0, userName=huangshifeng, userId=a9fa18776644, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ebb3e291762a, moduleTitle=IBD: 炎症性肠病患者的结直肠狭窄不能独立预测结直肠肿瘤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ebb3e291762a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1600146, encodeId=733d16001462c, content=<a href='/topic/show?id=508e6e03203' target=_blank style='color:#2F92EE;'>#炎症性肠病患者#</a>, objectTitle=IBD：NAFLD对炎症性肠病患者住院结局的影响, objectType=article, longId=729175, objectId=d8aee2917542, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d8aee2917542, replyNumber=0, likeNumber=89, createdTime=2022-06-13, rootId=0, userName=huangshifeng, userId=a9fa18776644, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d8aee2917542, moduleTitle=IBD：NAFLD对炎症性肠病患者住院结局的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d8aee2917542)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1600143, encodeId=cb1c1600143a7, content=<a href='/topic/show?id=508e6e03203' target=_blank style='color:#2F92EE;'>#炎症性肠病患者#</a>, objectTitle=IBD:炎症性肠病患者与癌症发生的长期风险关系, objectType=article, longId=728590, objectId=8ebde28590b5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8ebde28590b5, replyNumber=0, likeNumber=116, createdTime=2022-06-05, rootId=0, userName=zhouqu_8, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8ebde28590b5, moduleTitle=IBD:炎症性肠病患者与癌症发生的长期风险关系, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8ebde28590b5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1600142, encodeId=4fb21600142af, content=<a href='/topic/show?id=508e6e03203' target=_blank style='color:#2F92EE;'>#炎症性肠病患者#</a>, objectTitle=CGH: COVID-19疫苗对炎症性肠病患者有效且与疾病恶化无关, objectType=article, longId=728099, objectId=21c2e2809987, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=21c2e2809987, replyNumber=0, likeNumber=91, createdTime=2022-05-30, rootId=0, userName=huangshifeng, userId=a9fa18776644, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=21c2e2809987, moduleTitle=CGH: COVID-19疫苗对炎症性肠病患者有效且与疾病恶化无关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=21c2e2809987)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1600141, encodeId=ec51160014135, content=<a href='/topic/show?id=508e6e03203' target=_blank style='color:#2F92EE;'>#炎症性肠病患者#</a>, objectTitle=JCC:重组带状疱疹疫苗在炎症性肠病患者中是安全的, objectType=article, longId=727025, objectId=308be2702538, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=308be2702538, replyNumber=0, likeNumber=80, createdTime=2022-05-17, rootId=0, userName=huangshifeng, userId=a9fa18776644, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=308be2702538, moduleTitle=JCC:重组带状疱疹疫苗在炎症性肠病患者中是安全的, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=308be2702538)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1600140, encodeId=b7141600140fa, content=<a href='/topic/show?id=508e6e03203' target=_blank style='color:#2F92EE;'>#炎症性肠病患者#</a>, objectTitle=JGH:长期使用硫嘌呤不会增加炎症性肠病患者淋巴瘤和非黑色素瘤皮肤癌的风险, objectType=article, longId=726395, objectId=f5b7e2639539, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f5b7e2639539, replyNumber=0, likeNumber=91, createdTime=2022-05-10, rootId=0, userName=huangshifeng, userId=a9fa18776644, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f5b7e2639539, moduleTitle=JGH:长期使用硫嘌呤不会增加炎症性肠病患者淋巴瘤和非黑色素瘤皮肤癌的风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f5b7e2639539)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1600139, encodeId=83f3160013952, content=<a href='/topic/show?id=508e6e03203' target=_blank style='color:#2F92EE;'>#炎症性肠病患者#</a>, objectTitle=AP&T: 炎症性肠病患者使用抗抑郁药物的几率高于一般人群, objectType=article, longId=726033, objectId=ec74e26033e1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ec74e26033e1, replyNumber=0, likeNumber=96, createdTime=2022-05-04, rootId=0, userName=huangshifeng, userId=a9fa18776644, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ec74e26033e1, moduleTitle=AP&T: 炎症性肠病患者使用抗抑郁药物的几率高于一般人群, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ec74e26033e1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1600138, encodeId=be8116001387c, content=<a href='/topic/show?id=508e6e03203' target=_blank style='color:#2F92EE;'>#炎症性肠病患者#</a>, objectTitle=IBD: 炎症性肠病患者呼吸系统症状的患病率比一般人群要高, objectType=article, longId=726030, objectId=45f6e2603064, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=45f6e2603064, replyNumber=0, likeNumber=108, createdTime=2022-05-04, rootId=0, userName=huangshifeng, userId=a9fa18776644, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=45f6e2603064, moduleTitle=IBD: 炎症性肠病患者呼吸系统症状的患病率比一般人群要高, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=45f6e2603064)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1600144, encodeId=340b1600144d4, content=<a href='/topic/show?id=508e6e03203' target=_blank style='color:#2F92EE;'>#炎症性肠病患者#</a>, objectTitle=Dig Dis Sci：硫嘌呤单药治疗可有效维持轻中度炎症性肠病患者的临床缓解状态, objectType=article, longId=724927, objectId=7a46e249275e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7a46e249275e, replyNumber=0, likeNumber=76, createdTime=2022-04-26, rootId=0, userName=huangshifeng, userId=a9fa18776644, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7a46e249275e, moduleTitle=Dig Dis Sci：硫嘌呤单药治疗可有效维持轻中度炎症性肠病患者的临床缓解状态, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7a46e249275e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1600137, encodeId=cb53160013eaa, content=<a href='/topic/show?id=508e6e03203' target=_blank style='color:#2F92EE;'>#炎症性肠病患者#</a>, objectTitle=CGH: 生物制剂时代到来后炎症性肠病患者肠道切除和结肠切除术的发生率变化, objectType=article, longId=724421, objectId=15afe2442114, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=15afe2442114, replyNumber=0, likeNumber=90, createdTime=2022-04-18, rootId=0, userName=huangshifeng, userId=a9fa18776644, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=15afe2442114, moduleTitle=CGH: 生物制剂时代到来后炎症性肠病患者肠道切除和结肠切除术的发生率变化, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=15afe2442114)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1600136, encodeId=0b34160013659, content=<a href='/topic/show?id=508e6e03203' target=_blank style='color:#2F92EE;'>#炎症性肠病患者#</a>, objectTitle=IBD：炎症性肠病患者处于疾病活动期是新冠肺炎病情加重的危险因素, objectType=article, longId=723917, objectId=f2e0e2391768, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f2e0e2391768, replyNumber=0, likeNumber=88, createdTime=2022-04-11, rootId=0, userName=huangshifeng, userId=a9fa18776644, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f2e0e2391768, moduleTitle=IBD：炎症性肠病患者处于疾病活动期是新冠肺炎病情加重的危险因素, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f2e0e2391768)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

炎症性肠病患者

2020-05-29

ms3000000691298775 (审核中...)

前往app查看评论内容

Ready for editorial assignment 这个状态1w了，真难顶#炎症性肠病患者#

SCI REP-UK

2024-07-10发表于江西省

huangshifeng (审核中...)

前往app查看评论内容

#炎症性肠病患者#

UEG: 炎症性肠病患者患尖锐湿疣的风险明显增加

2022-09-15

huangshifeng (审核中...)

前往app查看评论内容

#炎症性肠病患者#

JGH：硫唑嘌呤治疗不会导致炎症性肠病患者淋巴瘤和非黑色素瘤皮肤癌的风险增加

2022-08-12

huangshifeng (审核中...)

前往app查看评论内容

#炎症性肠病患者#

AP&T: 炎症性肠病患者患痴呆风险明显增加

2022-08-12

huangshifeng (审核中...)

前往app查看评论内容

#炎症性肠病患者#

IBD: 炎症性肠病患者接受抗TNF治疗前后严重感染的风险变化

2022-07-11

huangshifeng (审核中...)

前往app查看评论内容

#炎症性肠病患者#

Clin Trans Gastroenterology: 载脂蛋白C3在炎症性肠病患者中明显下调可能影响心血管疾病

2022-07-05

huangshifeng (审核中...)

前往app查看评论内容

#炎症性肠病患者#

Gastroenterology：接受腹部手术的炎症性肠病患者术前肿瘤坏死因子抑制剂的治疗的安全性分析

2022-06-27

huangshifeng (审核中...)

前往app查看评论内容

#炎症性肠病患者#

AJG: 英夫利昔单抗与炎症性肠病患者的一般长期体重增加无关

2022-06-22

huangshifeng (审核中...)

前往app查看评论内容

#炎症性肠病患者#

JGH：乌司奴单抗(Ustekinumab)不会增加既往患有恶性肿瘤的炎症性肠病患者新发或复发癌症的风险

2022-06-21

huangshifeng (审核中...)

前往app查看评论内容

#炎症性肠病患者#

IBD: 炎症性肠病患者的结直肠狭窄不能独立预测结直肠肿瘤

2022-06-13

huangshifeng (审核中...)

前往app查看评论内容

#炎症性肠病患者#

IBD：NAFLD对炎症性肠病患者住院结局的影响

2022-06-13

zhouqu_8 (审核中...)

前往app查看评论内容

#炎症性肠病患者#

IBD:炎症性肠病患者与癌症发生的长期风险关系

2022-06-05

huangshifeng (审核中...)

前往app查看评论内容

#炎症性肠病患者#

CGH: COVID-19疫苗对炎症性肠病患者有效且与疾病恶化无关

2022-05-30

huangshifeng (审核中...)

前往app查看评论内容

#炎症性肠病患者#

JCC:重组带状疱疹疫苗在炎症性肠病患者中是安全的

2022-05-17

huangshifeng (审核中...)

前往app查看评论内容

#炎症性肠病患者#

JGH:长期使用硫嘌呤不会增加炎症性肠病患者淋巴瘤和非黑色素瘤皮肤癌的风险

2022-05-10

huangshifeng (审核中...)

前往app查看评论内容

#炎症性肠病患者#

AP&T: 炎症性肠病患者使用抗抑郁药物的几率高于一般人群

2022-05-04

huangshifeng (审核中...)

前往app查看评论内容

#炎症性肠病患者#

IBD: 炎症性肠病患者呼吸系统症状的患病率比一般人群要高

2022-05-04

huangshifeng (审核中...)

前往app查看评论内容

#炎症性肠病患者#

Dig Dis Sci：硫嘌呤单药治疗可有效维持轻中度炎症性肠病患者的临床缓解状态

2022-04-26

huangshifeng (审核中...)

前往app查看评论内容

#炎症性肠病患者#

CGH: 生物制剂时代到来后炎症性肠病患者肠道切除和结肠切除术的发生率变化

2022-04-18

huangshifeng (审核中...)

前往app查看评论内容

#炎症性肠病患者#

IBD：炎症性肠病患者处于疾病活动期是新冠肺炎病情加重的危险因素

2022-04-11

科室
- - 订阅+
  - 更多科室
工具
服务